Showing results (291-300 of 322) with videos related to

Sort By:
Pageof 33
American Journal of Hematology|November 6, 2009
Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 casesSung Yong Oh, Won Seog Kim, Seok Jin Kim, et al.
Blood Research|April 12, 2014
Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of LymphomaByung Woog Kang, Sang Kyun Sohn, Joon Ho Moon, et al.
Annals of Hematology|March 28, 2014
Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry studySukjoong Oh, Dong Hoe Koo, Min-Jung Kwon, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2016
Clinical Features and Survival of Patients With Follicular Lymphoma in KoreaSu-Hee Cho, Cheolwon Suh, Young Rok Do, et al.
Cancer Research and Treatment|March 30, 2023
Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) StudyYu Ri Kim, Jin Seok Kim, Won Seog Kim, et al.
Blood|December 15, 2010
Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy aloneSeok Jin Kim, Hye Jin Kang, Jin Seok Kim, et al.
Annals of Hematology|July 27, 2011
Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)Young-Woong Won, Jung Hye Kwon, Soon Il Lee, et al.
Clinical Lymphoma & Myeloma|September 4, 2008
Bortezomib and the increased incidence of herpes zoster in patients with multiple myelomaSeok Jin Kim, Kihyun Kim, Byung Soo Kim, et al.
BMC Cancer|June 24, 2010
Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) studyHo-Young Yhim, Hye Jin Kang, Yoon Hee Choi, et al.
Biomed Research International|July 23, 2014
Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: a prospective multicenter studyKi-Seong Eom, Seok Jin Kim, Je-Jung Lee, et al.
Pageof 33